Medi-Exametazime

Tc-MR-14

Indications
After radiolabelling with sodium pertechnetate (99mTc) solution, the solution obtained is indicated for

Neurology:

  • Evaluation of patients with cerebrovascular disease (specifically acute stroke, chronic ischemia, and transient ischemic attack)
  • Presurgical lateralization and localization of epileptogenic foci.
  • Evaluation of patients with suspected dementia (specifically Alzheimer’s disease and frontotemporal dementia)
  • Adjuvant technique in the diagnosis of brain death.

Infectious or inflammatory diseases:

  • Detection of sites of focal infection (e.g. abdominal abscess),
  • Investigation of pyrexia of unknown origin,
  • Evaluation of inflammatory conditions not associated with infection such as inflammatory bowel disease.

Labelling activity
0.37-2.2 GBq (10-60 mCi)

Shelf life
12 months

Shelf-life and storage conditions after radiolabelling
60 minutes, Do not store above 25°C. Do not refrigerate or freeze after radiolabelling.

Registration number NL
RVG 127837

Registration number BE
BE 591537

Registration number LUX
2021090180

Van Overeem BV is the exclusive distributor of this product in The Netherlands, Belgium and Luxemburg.